Toggle navigation
Home
Search
Services
Blog
Contact
About
New Nonviral Gene Therapy for Adult T Cell Leukemia
Song, Sun U.
Massachusetts General Hospital, Boston, MA, United States
Search 11 grants from Sun Song
Search grants from Massachusetts General Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Probabilistic models of protein and RNA structure
Service Use and Course of Drinking in Rural Drinkers
Functional Substructure of Flagellar Dynein
Lipoprotein Receptors in Health and Disease
Phase Ib Trial of IL-2 Alone and with Cytotoxic Cells
Recently added grants:
Brain regional extracellular matrix molecules, corticostriatal circuitry function and alcohol drinking in monkeys and mice
Animal & Resource Core
Bioinformatics Core
Information Dissemination Core
Behavioral and Neural Indicators of Prodromal Alzheimer's Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA076656-02
Application #
2700785
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Lohrey, Nancy
Project Start
1998-05-01
Project End
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Related projects
NIH 1999
F32 CA
New Nonviral Gene Therapy for Adult T Cell Leukemia
Song, Sun U. / Massachusetts General Hospital
NIH 1998
F32 CA
New Nonviral Gene Therapy for Adult T Cell Leukemia
Song, Sun U. / Massachusetts General Hospital
NIH 1997
F32 CA
New Nonviral Gene Therapy for Adult T Cell Leukemia
Song, Sun U. / Massachusetts General Hospital
Publications
Song, S U; Boyce, F M
(2001)
Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin).
Exp Mol Med 33:46-53
Comments
Be the first to comment on this grant